Highlights and Quick Summary
- Long-term assets (Other) for the quarter ending September 30, 2023 was $15.3 Million (a 0.0% decrease compared to previous quarter)
- Year-over-year quarterly Long-term assets (Other) increased by 1.12%
- Annual Long-term assets (Other) for 2022 was $15.1 Million (a -2.93% decrease from previous year)
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Long-term assets (Other) of Prime Medicine, Inc.
Most recent Long-term assets (Other)of PRME including historical data for past 10 years.Interactive Chart of Long-term assets (Other) of Prime Medicine, Inc.
Prime Medicine, Inc. Long-term assets (Other) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $15.31 | $15.31 | $15.14 | – | – |
| 2022 | – | – | $15.14 | $19.11 | $15.14 |
| 2021 | – | – | – | – | $15.6 |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology